Medication Safety Information

The medications prescribed at RITSA Health, including GLP-1 receptor agonists such as semaglutide (Wegovy®) and tirzepatide (Zepbound®), are FDA-approved when used as indicated. The information below is for educational purposes and is not a substitute for the medical advice of your physician.

Important Warnings

GLP-1 medications may carry a boxed warning regarding thyroid C-cell tumors. Do not use these medications if you or a family member has had medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Common Side Effects

Side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, and injection site reactions. Most are mild and improve over time.

Serious Side Effects — Seek Care

Contact your physician or seek emergency care if you experience severe abdominal pain (possible pancreatitis), gallbladder symptoms, signs of an allergic reaction, vision changes, or symptoms of low blood sugar.

Who Should Not Take These Medications

These medications are not for everyone — including individuals who are pregnant or breastfeeding, those with certain endocrine conditions, or those with a history of severe gastrointestinal disease. Your physician will determine eligibility during your evaluation.

Emergencies

Telehealth is not for emergencies. Call 911 if you are experiencing a medical emergency.